NCT02079389

Brief Summary

The following project deals with a Danish multicenter trial that evaluates the value of Laparoscopic Ultrasound examination (LUS) in laparoscopic surgery for colon and rectum cancer (CRC). The project "The value of laparoscopic ultrasound in patients undergoing laparoscopic resection for colon and rectum cancer. - A prospective randomized trial" is part of a ph.d- study at the University of Southern Denmark in collaboration with several surgical departments at hospitals in Southern Denmark. The primary purpose is to investigate whether the use of laparoscopic ultrasound examination (LUS) will change the stage of the tumor, lymph node and metastasis (TNM stage) and the surgical approach in patients undergoing laparoscopic surgery for colorectal cancer (CRC). As a secondary objective; an evaluation of the use of LUS will change the treatment strategy for the individual patient with CRC. As an other objective we wants to investigate whether the use of contrast enhanced ultrasound examination in connection with LUS procedure increases the number of detected liver metastases.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
280

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2013

Typical duration for not_applicable

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2013

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

February 10, 2014

Completed
23 days until next milestone

First Posted

Study publicly available on registry

March 5, 2014

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2015

Completed
Last Updated

May 5, 2015

Status Verified

May 1, 2013

Enrollment Period

1.6 years

First QC Date

February 10, 2014

Last Update Submit

May 4, 2015

Conditions

Keywords

colon cancerrectum cancerlaparoscopic ultrasoundLUSContrast enhanced ultrasoundCEUSPeroperative TNM stagingscreening for liver metastases

Outcome Measures

Primary Outcomes (1)

  • A change in the stage of Tumor, lymph Node and metastases (TNM-stage)

    When using laparoscopic ultrasound examination (LUS) during laparoscopic resection for colon and rectum cancer, it is possible to scan the tumor, lymph nodes around the tumor, retroperitoneum and the liver. Thereby it is possible to make a preoperative TNM staging. Will the use of LUS change the stage of Tumor lymph Node and Metastases (TNM stage) compared to the preoperative TNM evaluation. The procedure LUS takes approximately 5 to 10 minutes. Tree months after surgery the patients will get a CT scan of the liver to ensure that the LUS did not miss any metastasis.

    3 months

Secondary Outcomes (1)

  • A change in the postoperative treatment strategy

    3 months

Other Outcomes (1)

  • Does the use of contrast enhanced ultrasound examination during surgery for colon and rectum cancer provides more findings of liver metastases?

    10 minutes

Study Arms (2)

Lap+Lus

ACTIVE COMPARATOR

The included patients randomly assigned either to the department's standard laparoscopic (Lap) surgery or standard laparoscopic surgery (lap) plus a LUS examination. In the intervention arm the intra-abdominal conditions are also assessed by laparoscopy, but then supplemented with a LUS examination of the primary tumor, liver and retroperitoneum. All the included patients are getting a CT scan of the abdomen after 3 months.

Device: Lap+Lus

laparoscopic examination (Lap)

NO INTERVENTION

The included patients randomly assigned either to the department's standard laparoscopic (Lap) surgery or standard laparoscopic surgery (lap) plus a LUS examination. In the standard arm (Lap) the conditions at the abdomen is only assessed by laparoscopy immediately prior to the resection. All the included patients are getting a CT scan of the abdomen after 3 months.

Interventions

Lap+LusDEVICE

In the standard arm (Lap) the conditions at the abdomen is only assessed by laparoscopy immediately prior to the resection. In the intervention arm the intra-abdominal conditions are also assessed by laparoscopy, but then supplemented with a laparoscopic ultrasound examination of the primary tumor, liver and retroperitoneum. All patients are given an CT scan of the abdomen after 3 months.

Also known as: BK medicals, ultrasound solutions
Lap+Lus

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with colon and rectum cancer without known metastasis
  • Patients who gives informed consent
  • Patients who are referral to laparoscopic surgery

You may not qualify if:

  • Patients who are not able to give informed consent
  • Patients who are under 18 of age Patients with known metastasis.
  • Patients who are allergic to contrast agents
  • Patients who are pregnant or lactating

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Esbjerg Hospital

Esbjerg, Esbjerg, 6700, Denmark

Location

Odense University Hospital

Odense, Odense, 5000, Denmark

Location

Svendborg Hospital

Svendborg, Svendborg, 5700, Denmark

Location

Lillebaelt Hospital

Vejle, Vejle, 7100, Denmark

Location

Related Publications (1)

  • Ellebaek SB, Fristrup CW, Hovendal C, Qvist N, Bundgaard L, Salomon S, Stovring J, Mortensen MB. Randomized clinical trial of laparoscopic ultrasonography before laparoscopic colorectal cancer resection. Br J Surg. 2017 Oct;104(11):1462-1469. doi: 10.1002/bjs.10636.

MeSH Terms

Conditions

Colonic NeoplasmsRectal Neoplasms

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Study Officials

  • Signe bremholm Rasmussen, MD

    Odense University Hospital

    STUDY DIRECTOR
  • Michael Bau Mortensen, professor

    Odense University Hospital

    PRINCIPAL INVESTIGATOR
  • Claus Fristrup, ph.d

    Odense University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

February 10, 2014

First Posted

March 5, 2014

Study Start

May 1, 2013

Primary Completion

December 1, 2014

Study Completion

April 1, 2015

Last Updated

May 5, 2015

Record last verified: 2013-05

Locations